Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- CheckyesterdayChange DetectedThe Publications section now references 'Anticoagulants for people hospitalised with COVID-19: a rapid review' as the source, updating the wording of the cited Cochrane review. This reflects a bibliographic clarification rather than a substantive change to the study details.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This indicates a minor site release update without altering the study information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.5.2 was added and revision: v3.5.0 was removed, indicating a version update.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated to v3.4.2, and administrative notices about government funding lapse and NIH operating status were removed.SummaryDifference0.4%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.